Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MOHIT KHERA and MOHIT KHERA.
MOHIT KHERA
Connection Strength
57.679
MOHIT KHERA
  1. Regenerative therapies for erectile dysfunction: a systematic review, Bayesian network meta-analysis, and meta-regression. J Sex Med. 2024 Oct 17.
    View in: PubMed
    Score: 0.995
  2. Erectile dysfunction as a holistic indicator of well-being: a narrative review. Sex Med Rev. 2024 Oct 04.
    View in: PubMed
    Score: 0.992
  3. Lessons learned from the Sexual Medicine Society of North America fellowship bootcamp. J Sex Med. 2024 Sep 28; 21(10):961-966.
    View in: PubMed
    Score: 0.991
  4. Advancements in ectopic reservoir placement for inflatable penile prostheses. Sex Med Rev. 2024 Sep 25; 12(4):770-781.
    View in: PubMed
    Score: 0.991
  5. Safety and efficacy of enclomiphene and clomiphene for hypogonadal men. Transl Androl Urol. 2024 Sep 30; 13(9):1984-1990.
    View in: PubMed
    Score: 0.990
  6. Newer formulations of oral testosterone undecanoate: development and liver side effects. Sex Med Rev. 2024 Sep 18.
    View in: PubMed
    Score: 0.989
  7. Lessons learned from the TRAVERSE trial. J Sex Med. 2024 Sep 03; 21(9):746-748.
    View in: PubMed
    Score: 0.986
  8. Long-Term Satisfaction With Collagenase Clostridium Histolyticum for Peyronie's Disease: Clinical Predictors and Side Effect Profile. Urol Pract. 2024 Sep 03; 101097UPJ0000000000000696.
    View in: PubMed
    Score: 0.986
  9. Sexual Medicine Society of North America (SMSNA)/American Urological Association (AUA) telemedicine and men's health white paper. J Sex Med. 2024 Mar 28; 21(4):318-332.
    View in: PubMed
    Score: 0.957
  10. First-time orgasm in a young man with lifelong anorgasmia after flibanserin use: a case report. Sex Med. 2023 Dec; 11(6):qfad066.
    View in: PubMed
    Score: 0.943
  11. Androgen deprivation therapy for prostate cancer and neurocognitive disorders: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2024 Sep; 27(3):507-519.
    View in: PubMed
    Score: 0.942
  12. Stem cell therapy for erectile dysfunction: a systematic review. Sex Med Rev. 2023 12 23; 12(1):87-93.
    View in: PubMed
    Score: 0.940
  13. Hyperbaric oxygen therapy as a treatment for erectile dysfunction: a meta-analysis. Sex Med Rev. 2023 12 23; 12(1):94-99.
    View in: PubMed
    Score: 0.940
  14. Will you go the distance? A satisfaction survey of telemedicine in sexual medicine. Sex Med. 2023 Dec; 11(6):qfad060.
    View in: PubMed
    Score: 0.939
  15. Effect of aerobic exercise on erectile function: systematic review and meta-analysis of randomized controlled trials. J Sex Med. 2023 11 30; 20(12):1369-1375.
    View in: PubMed
    Score: 0.936
  16. Implantable Penile Prosthesis for Erectile Dysfunction: Insurance Coverage in the United States. Urol Pract. 2023 09; 10(5):501-510.
    View in: PubMed
    Score: 0.917
  17. Quantifying the number of US men with erectile dysfunction who are potential candidates for penile prosthesis implantation. Sex Med. 2023 Apr; 11(2):qfad010.
    View in: PubMed
    Score: 0.896
  18. The Low Submuscular Reservoir Placement With Transfascial Fixation for Inflatable Penile Prostheses. J Sex Med. 2022 08; 19(8):1309-1312.
    View in: PubMed
    Score: 0.846
  19. Testosterone replacement therapy and cardiovascular disease. Int J Impot Res. 2022 Nov; 34(7):685-690.
    View in: PubMed
    Score: 0.821
  20. The Potential for Pharmacological Interventions for Low Sex Drive in Men. J Sex Med. 2022 02; 19(2):165-169.
    View in: PubMed
    Score: 0.820
  21. Ectopic low submuscular pressure regulating balloon placement with transfascial fixation for artificial urinary sphincter. Can J Urol. 2021 12; 28(6):10936-10940.
    View in: PubMed
    Score: 0.815
  22. Differential Gene Expression in Post-Finasteride Syndrome Patients. J Sex Med. 2021 09; 18(9):1479-1490.
    View in: PubMed
    Score: 0.793
  23. Testosterone's Role in COVID-19. J Sex Med. 2021 05; 18(5):843-848.
    View in: PubMed
    Score: 0.776
  24. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk. J Sex Med. 2021 01; 18(1):83-98.
    View in: PubMed
    Score: 0.762
  25. Controversies in Testosterone Therapy. Sex Med Rev. 2021 01; 9(1):149-159.
    View in: PubMed
    Score: 0.761
  26. Is there still a place for malleable penile implants in the United States? Wilson's Workshop #18. Int J Impot Res. 2023 Mar; 35(2):82-89.
    View in: PubMed
    Score: 0.761
  27. Hypogonadism management and cardiovascular health. Postgrad Med. 2020 Dec; 132(sup4):35-41.
    View in: PubMed
    Score: 0.754
  28. Controversies with testosterone therapy. Can J Urol. 2020 08; 27(S3):20-23.
    View in: PubMed
    Score: 0.743
  29. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia. Transl Androl Urol. 2020 Jun; 9(3):1201-1209.
    View in: PubMed
    Score: 0.734
  30. Bipolar Androgen Therapy in Prostate Cancer (Update). J Sex Med. 2020 05; 17(5):831-834.
    View in: PubMed
    Score: 0.718
  31. A Critique of the AUA Guidelines on Testosterone Deficiency. J Sex Med. 2020 04; 17(4):561-564.
    View in: PubMed
    Score: 0.710
  32. Editorial Comment. J Urol. 2019 09; 202(3):610.
    View in: PubMed
    Score: 0.694
  33. An Update on Regenerative Medicine Clinical Trials in Erectile Dysfunction: Have We Made Any Progress? Eur Urol Focus. 2019 Jul; 5(4):536-538.
    View in: PubMed
    Score: 0.686
  34. Effect of Body Weight on Sexual Function in Men and Women. Curr Sex Health Rep. 2019 Mar; 11(1):52-59.
    View in: PubMed
    Score: 0.668
  35. Testosterone Replacement Therapy Versus Clomiphene Citrate in the Young Hypogonadal Male. Eur Urol Focus. 2018 04; 4(3):321-323.
    View in: PubMed
    Score: 0.649
  36. The Role of Testosterone Therapy in the Setting of Prostate Cancer. Curr Urol Rep. 2018 Jun 30; 19(8):67.
    View in: PubMed
    Score: 0.643
  37. Penile Prosthesis Implantation in Patients With Peyronie's Disease: Results of the PROPPER Study Demonstrates a Decrease in Patient-Reported Depression. J Sex Med. 2018 05; 15(5):786-788.
    View in: PubMed
    Score: 0.633
  38. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism. J Sex Med. 2018 02; 15(2):148-158.
    View in: PubMed
    Score: 0.625
  39. Hypogonadism: Therapeutic Risks, Benefits, and Outcomes. Med Clin North Am. 2018 Mar; 102(2):361-372.
    View in: PubMed
    Score: 0.618
  40. Alternatives to Testosterone Therapy: A Review. Sex Med Rev. 2018 01; 6(1):106-113.
    View in: PubMed
    Score: 0.617
  41. Testosterone therapy improves erectile function and libido in hypogonadal men. Curr Opin Urol. 2017 Nov; 27(6):511-515.
    View in: PubMed
    Score: 0.614
  42. Testosterone inhibits the growth of prostate cancer xenografts in nude mice. BMC Cancer. 2017 Sep 07; 17(1):635.
    View in: PubMed
    Score: 0.608
  43. Erectile dysfunction, metabolic syndrome, and cardiovascular risks: facts and controversies. Transl Androl Urol. 2017 Feb; 6(1):28-36.
    View in: PubMed
    Score: 0.583
  44. Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured Population. J Sex Med. 2017 01; 14(1):88-97.
    View in: PubMed
    Score: 0.577
  45. Testosterone therapy and prostate cancer. Transl Androl Urol. 2016 Dec; 5(6):909-920.
    View in: PubMed
    Score: 0.576
  46. Diagnosis and Treatment of Testosterone Deficiency: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM?2015). J Sex Med. 2016 12; 13(12):1787-1804.
    View in: PubMed
    Score: 0.576
  47. Editorial Comment on "Couple-Based Psychosexual Support Following Prostate Cancer Surgery: Results of a Feasibility Pilot Randomized Control Trial". J Sex Med. 2016 08; 13(8):1243-4.
    View in: PubMed
    Score: 0.563
  48. Adult-Onset Hypogonadism. Mayo Clin Proc. 2016 07; 91(7):908-26.
    View in: PubMed
    Score: 0.559
  49. Testosterone Therapies. Urol Clin North Am. 2016 May; 43(2):185-93.
    View in: PubMed
    Score: 0.549
  50. Male hormones and men's quality of life. Curr Opin Urol. 2016 Mar; 26(2):152-7.
    View in: PubMed
    Score: 0.547
  51. Testosterone is Protective against Cardiac Disease: Pro. J Urol. 2016 04; 195(4 Pt 1):831-2.
    View in: PubMed
    Score: 0.543
  52. Changing paradigm of men's health. Indian J Urol. 2016 Jan-Mar; 32(1):5.
    View in: PubMed
    Score: 0.541
  53. The Evolution of the Inflatable Penile Prosthesis Reservoir and Surgical Placement. J Sex Med. 2015 Nov; 12 Suppl 7:464-7.
    View in: PubMed
    Score: 0.534
  54. Testosterone Replacement in Men with Treated and Untreated Prostate Cancer. Sex Med Rev. 2013 Oct; 1(3):143-149.
    View in: PubMed
    Score: 0.533
  55. Testosterone Therapy for Female Sexual Dysfunction. Sex Med Rev. 2015 Jul; 3(3):137-144.
    View in: PubMed
    Score: 0.532
  56. Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer. Asian J Androl. 2015 Sep-Oct; 17(5):807-10.
    View in: PubMed
    Score: 0.528
  57. Testosterone Therapy after Radiation Therapy for Low, Intermediate and High Risk Prostate Cancer. J Urol. 2015 Nov; 194(5):1271-6.
    View in: PubMed
    Score: 0.519
  58. Mesenchymal stem cell therapy for the treatment of erectile dysfunction. J Sex Med. 2015 May; 12(5):1105-6.
    View in: PubMed
    Score: 0.516
  59. Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis. J Sex Med. 2015 Apr; 12(4):975-84.
    View in: PubMed
    Score: 0.510
  60. Controversies in testosterone supplementation therapy. Asian J Androl. 2015 Mar-Apr; 17(2):175-6.
    View in: PubMed
    Score: 0.510
  61. RE: Testosterone treatment is a potent tumor promoter for the rat prostate. Endocrinology. 2015 Jan; 156(1):L1-2.
    View in: PubMed
    Score: 0.505
  62. Alternative treatment modalities for the hypogonadal patient. Curr Urol Rep. 2014 Jul; 15(7):417.
    View in: PubMed
    Score: 0.487
  63. Reply to Julia Klap and Kevin R. Loughlin's letter to the editor re: Mohit Khera, David Crawford, Alvaro Morales, Andrea Salonia, Abraham Morgentaler. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol 2014;65:115-23. Eur Urol. 2014 Aug; 66(2):e33.
    View in: PubMed
    Score: 0.482
  64. Patients with testosterone deficit syndrome and depression. Arch Esp Urol. 2013 Sep; 66(7):729-36.
    View in: PubMed
    Score: 0.460
  65. A new era of testosterone and prostate cancer: from physiology to clinical implications. Eur Urol. 2014 Jan; 65(1):115-23.
    View in: PubMed
    Score: 0.459
  66. Nitric oxide-releasing polymeric microspheres improve diabetes-related erectile dysfunction. J Sex Med. 2013 Aug; 10(8):1915-25.
    View in: PubMed
    Score: 0.453
  67. 12-month observation of testosterone replacement effectiveness in a general population of men. Postgrad Med. 2013 Mar; 125(2):8-18.
    View in: PubMed
    Score: 0.444
  68. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013 Aug; 190(2):639-44.
    View in: PubMed
    Score: 0.442
  69. The 20-year public health impact and direct cost of testosterone deficiency in U.S. men. J Sex Med. 2013 Feb; 10(2):562-9.
    View in: PubMed
    Score: 0.432
  70. Testosterone replacement in normal and pathologic prostate. Horm Mol Biol Clin Investig. 2012 Oct; 11(3):347-53.
    View in: PubMed
    Score: 0.432
  71. Pharmacokinetic evaluation and dosing of subcutaneous testosterone pellets. J Androl. 2012 Sep-Oct; 33(5):927-37.
    View in: PubMed
    Score: 0.415
  72. The effect of testosterone supplementation on depression symptoms in hypogonadal men from the Testim Registry in the US (TRiUS). Aging Male. 2012 Mar; 15(1):14-21.
    View in: PubMed
    Score: 0.406
  73. Subcutaneous implantable testosterone pellets overcome noncompliance in adolescents with Klinefelter syndrome. J Androl. 2012 Jul-Aug; 33(4):570-3.
    View in: PubMed
    Score: 0.402
  74. Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011 Nov; 8(11):3204-13.
    View in: PubMed
    Score: 0.399
  75. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory. J Urol. 2011 Sep; 186(3):1005-11.
    View in: PubMed
    Score: 0.397
  76. Erectile dysfunction. BMJ Clin Evid. 2011 Jun 29; 2011.
    View in: PubMed
    Score: 0.396
  77. Testosterone therapy in men with untreated prostate cancer. J Urol. 2011 Apr; 185(4):1256-60.
    View in: PubMed
    Score: 0.386
  78. Revision of penile prosthesis surgery after use of penile traction therapy to increase erect penile length: case report and review of the literature. J Sex Med. 2011 Feb; 8(2):607-11.
    View in: PubMed
    Score: 0.379
  79. Androgen replacement therapy after prostate cancer treatment. Curr Urol Rep. 2010 Nov; 11(6):393-9.
    View in: PubMed
    Score: 0.378
  80. The female factor: predicting compliance with a post-prostatectomy erectile preservation program. J Sex Med. 2010 Nov; 7(11):3659-65.
    View in: PubMed
    Score: 0.374
  81. Testosterone replacement therapy following radical prostatectomy. J Sex Med. 2009 Apr; 6(4):1165-1170.
    View in: PubMed
    Score: 0.334
  82. Androgens and erectile function: a case for early androgen use in postprostatectomy hypogonadal men. J Sex Med. 2009 Mar; 6 Suppl 3:234-8.
    View in: PubMed
    Score: 0.334
  83. Evolving approach to the varicocele. Urol Clin North Am. 2008 May; 35(2):183-9, viii.
    View in: PubMed
    Score: 0.318
  84. The role of testosterone replacement therapy following radical prostatectomy. Urol Clin North Am. 2007 Nov; 34(4):549-53, vi.
    View in: PubMed
    Score: 0.307
  85. The role of the prostacyclin receptor antagonist RO3244019 in treating neurogenic detrusor overactivity after spinal cord injury in rats. BJU Int. 2007 Feb; 99(2):442-6.
    View in: PubMed
    Score: 0.291
  86. Can preoperative behavioral training reduce postprostatectomy incontinence? Nat Clin Pract Urol. 2006 Jun; 3(6):302-3.
    View in: PubMed
    Score: 0.278
  87. In vivo effects of botulinum toxin A on visceral sensory function in chronic spinal cord-injured rats. Urology. 2005 Jul; 66(1):208-12.
    View in: PubMed
    Score: 0.261
  88. Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int. 2004 Dec; 45(7):987-93.
    View in: PubMed
    Score: 0.251
  89. Botulinum toxin type A: a novel approach to the treatment of recurrent urethral strictures. J Urol. 2004 Aug; 172(2):574-5.
    View in: PubMed
    Score: 0.245
  90. Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism. Andrology. 2024 Sep 10.
    View in: PubMed
    Score: 0.062
  91. Can semen analysis be utilized as a screening tool for overall health in young men? Int J Impot Res. 2024 Jun 29.
    View in: PubMed
    Score: 0.061
  92. Changes in post-transplant serum testosterone levels in men undergoing lung transplantation: a pilot study using the TriNetX Research Network. Int J Impot Res. 2024 Jun 05.
    View in: PubMed
    Score: 0.061
  93. Cosmetic penile enhancement procedures: an SMSNA position statement. J Sex Med. 2024 May 28; 21(6):573-578.
    View in: PubMed
    Score: 0.061
  94. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):569-580.
    View in: PubMed
    Score: 0.059
  95. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 12 01; 6(12):e2348692.
    View in: PubMed
    Score: 0.058
  96. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13; 389(2):107-117.
    View in: PubMed
    Score: 0.057
  97. Increasing Role of the Advanced Practice Provider in Men's Health Clinics: An Analysis of Medicare and Commercial Claims in the United States. Urol Pract. 2023 07; 10(4):320-325.
    View in: PubMed
    Score: 0.056
  98. Oral testosterone therapy: past, present, and future. Sex Med Rev. 2023 04 03; 11(2):124-138.
    View in: PubMed
    Score: 0.056
  99. Recognizing the True Value of Testosterone Therapy in Health Care. Androg Clin Res Ther. 2022; 3(1):217-223.
    View in: PubMed
    Score: 0.055
  100. Is urgent surgical management necessary for priapism in pediatric patients with hematologic conditions? J Pediatr Urol. 2022 08; 18(4):528.e1-528.e6.
    View in: PubMed
    Score: 0.053
  101. Joint association of statins and testosterone replacement therapy with cardiovascular disease among older men with prostate cancer: SEER-Medicare 2007-2015. Cancer Epidemiol. 2022 08; 79:102172.
    View in: PubMed
    Score: 0.052
  102. Long-Term Survival Rates of Inflatable Penile Prostheses: Systematic Review and Meta-Analysis. Urology. 2022 08; 166:6-10.
    View in: PubMed
    Score: 0.052
  103. A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism. Andrology. 2022 05; 10(4):669-676.
    View in: PubMed
    Score: 0.051
  104. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022; 33(1):65-76.
    View in: PubMed
    Score: 0.051
  105. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 03; 245:41-50.
    View in: PubMed
    Score: 0.051
  106. Comparative assessment of outcomes and adverse effects using two different intramuscular testosterone therapy regimens: 100?mg IM weekly or 200?mg IM biweekly. Int J Impot Res. 2022 Sep; 34(6):558-563.
    View in: PubMed
    Score: 0.050
  107. Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):630-637.
    View in: PubMed
    Score: 0.049
  108. The role of testosterone replacement therapy and statin use, and their combination, in prostate cancer. Cancer Causes Control. 2021 Sep; 32(9):965-976.
    View in: PubMed
    Score: 0.049
  109. Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A. Can Urol Assoc J. 2021 May; 15(5):E234-E243.
    View in: PubMed
    Score: 0.049
  110. Independent and Joint Effects of Testosterone Replacement Therapy and Statins use on the Risk of Prostate Cancer Among White, Black, and Hispanic Men. Cancer Prev Res (Phila). 2021 07; 14(7):719-728.
    View in: PubMed
    Score: 0.049
  111. The Emerging Critical Role of Telemedicine in the Urology Clinic: A Practical Guide. Sex Med Rev. 2021 04; 9(2):289-295.
    View in: PubMed
    Score: 0.049
  112. Testosterone Therapy After Prostate Cancer Treatment: A Review of Literature. Sex Med Rev. 2021 07; 9(3):393-405.
    View in: PubMed
    Score: 0.048
  113. Is treatment of hypogonadism safe for men after a solid organ transplant? Results from a retrospective controlled cohort study. Int J Impot Res. 2022 Jan; 34(1):50-54.
    View in: PubMed
    Score: 0.047
  114. Response to Commentary on Contemporary Considerations in a Man With Low Sex Drive. J Sex Med. 2020 11; 17(11):2311.
    View in: PubMed
    Score: 0.047
  115. Novel Treatments of Erectile Dysfunction: Review of the Current Literature. Sex Med Rev. 2021 01; 9(1):123-132.
    View in: PubMed
    Score: 0.046
  116. Contemporary Considerations in the Pathophysiology of Low Sex Drive in Men. J Sex Med. 2020 06; 17(6):1049-1052.
    View in: PubMed
    Score: 0.045
  117. Association of the extent of therapy with prostate cancer in those receiving testosterone therapy in a US commercial insurance claims database. Clin Endocrinol (Oxf). 2019 12; 91(6):885-891.
    View in: PubMed
    Score: 0.044
  118. Paediatric and adult-onset male hypogonadism. Nat Rev Dis Primers. 2019 May 30; 5(1):38.
    View in: PubMed
    Score: 0.043
  119. Erectile Dysfunction: AUA Guideline. J Urol. 2018 09; 200(3):633-641.
    View in: PubMed
    Score: 0.040
  120. Caffeine intake is not associated with serum testosterone levels in adult men: cross-sectional findings from the NHANES 1999-2004 and 2011-2012. Aging Male. 2019 Mar; 22(1):45-54.
    View in: PubMed
    Score: 0.040
  121. The state of testosterone therapy since the FDA's 2015 labelling changes: Indications and cardiovascular risk. Clin Endocrinol (Oxf). 2018 07; 89(1):3-10.
    View in: PubMed
    Score: 0.040
  122. Inflatable penile prosthesis implant length with baseline characteristic correlations: preliminary analysis of the PROPPER study. Transl Androl Urol. 2017 Dec; 6(6):1167-1174.
    View in: PubMed
    Score: 0.039
  123. Recent advances in the treatment of erectile dysfunction. Postgrad Med J. 2017 Nov; 93(1105):679-685.
    View in: PubMed
    Score: 0.038
  124. Practice Patterns in the Diagnosis and Management of Hypogonadism: A Survey of Sexual Medicine Society of North America Members. Urology. 2017 Aug; 106:87-95.
    View in: PubMed
    Score: 0.037
  125. Sexual Rehabilitation After Treatment for Prostate Cancer-Part 1: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):285-296.
    View in: PubMed
    Score: 0.037
  126. Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2017 Mar; 14(3):297-315.
    View in: PubMed
    Score: 0.037
  127. Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction. J Sex Med. 2016 08; 13(8):1183-98.
    View in: PubMed
    Score: 0.035
  128. Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015). J Sex Med. 2016 Apr; 13(4):465-88.
    View in: PubMed
    Score: 0.034
  129. Diagnosing secondary hypogonadism: important consequences for fertility and reversibility. BJU Int. 2016 Apr; 117(4):552-4.
    View in: PubMed
    Score: 0.033
  130. The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data. J Urol. 2016 Feb; 195(2):427-33.
    View in: PubMed
    Score: 0.033
  131. Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen. Sex Med. 2015 Sep; 3(3):165-73.
    View in: PubMed
    Score: 0.033
  132. Peyronie's Disease: AUA Guideline. J Urol. 2015 Sep; 194(3):745-53.
    View in: PubMed
    Score: 0.032
  133. The nanochannel delivery system for constant testosterone replacement therapy. J Sex Med. 2015 Jun; 12(6):1375-80.
    View in: PubMed
    Score: 0.032
  134. Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clin Proc. 2015 Feb; 90(2):224-51.
    View in: PubMed
    Score: 0.032
  135. Delivering enhanced testosterone replacement therapy through nanochannels. Adv Healthc Mater. 2015 Feb 18; 4(3):446-51.
    View in: PubMed
    Score: 0.031
  136. Polymorphisms of the androgen receptor gene and hormonal contraceptive induced provoked vestibulodynia. J Sex Med. 2014 Nov; 11(11):2764-71.
    View in: PubMed
    Score: 0.031
  137. The safety of testosterone supplementation therapy in prostate cancer. Nat Rev Urol. 2014 Sep; 11(9):526-30.
    View in: PubMed
    Score: 0.031
  138. Commentary: Who is a candidate for testosterone therapy? A synthesis of international expert opinions. J Sex Med. 2014 Jul; 11(7):1636-45.
    View in: PubMed
    Score: 0.030
  139. North American consensus document on infection of penile prostheses. Urology. 2013 Oct; 82(4):937-42.
    View in: PubMed
    Score: 0.029
  140. Current opinions on alternative reservoir placement for inflatable penile prosthesis among members of the Sexual Medicine Society of North America. J Sex Med. 2013 Aug; 10(8):2115-20.
    View in: PubMed
    Score: 0.028
  141. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry. Postgrad Med. 2013 Mar; 125(2):19-29.
    View in: PubMed
    Score: 0.028
  142. The treatment of hypogonadism in?men of reproductive age. Fertil Steril. 2013 Mar 01; 99(3):718-24.
    View in: PubMed
    Score: 0.027
  143. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS). Clin Interv Aging. 2012; 7:321-30.
    View in: PubMed
    Score: 0.027
  144. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS). Pain Med. 2012 May; 13(5):688-98.
    View in: PubMed
    Score: 0.026
  145. A multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(?)) insertion. J Sex Med. 2012 Feb; 9(2):594-601.
    View in: PubMed
    Score: 0.026
  146. Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocr Disord. 2011 Nov 01; 11:18.
    View in: PubMed
    Score: 0.025
  147. Favorable female sexual function is associated with patient satisfaction after inflatable penile prosthesis implantation. J Sex Med. 2011 Jul; 8(7):1996-2001.
    View in: PubMed
    Score: 0.025
  148. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency. Postgrad Med. 2011 May; 123(3):17-27.
    View in: PubMed
    Score: 0.024
  149. Reply by authors. J Urol. 2010 Jun; 183(6):2315.
    View in: PubMed
    Score: 0.023
  150. Varicocele repair in patients with nonobstructive azoospermia: a meta-analysis. J Urol. 2010 Jun; 183(6):2309-15.
    View in: PubMed
    Score: 0.023
  151. Percutaneous treatment of varicocele with microcoil embolization: comparison of treatment outcome with laparoscopic varicocelectomy. Vascular. 2009 Nov-Dec; 17 Suppl 3:S129-36.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.